GEMO, a national resource to study genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 pathogenic variant carriers

Lesueur, F., Mebirouk, N., Jiao, Y., Barjhoux, L., Belotti, M., Laurent, M., … Stoppa-Lyonnet, D. (2018). GEMO, a national resource to study genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 pathogenic variant carriers. Frontiers in Oncology, 8(OCT). https://doi.org/10.3389/fonc.2018.00490